A-g Marcelin
Paris, France
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 18 publications
A case series of intermittent nucleoside analogue-based (NA) regimen to maintain HBV virological suppression in coinfected HBV/HIV patients with suppressed viremia.
Journal: Infectious diseases now
Published: March 08, 2024
High seroconversion rate but low antibody titers after two injections of BNT162b2 (Pfizer-BioNTech) vaccine in patients treated with chemotherapy for solid cancers.
Journal: Annals of oncology : official journal of the European Society for Medical Oncology
Published: May 17, 2021
Weak immunogenicity after a single dose of SARS-CoV-2 mRNA vaccine in treated cancer patients.
Journal: Annals of oncology : official journal of the European Society for Medical Oncology
Published: April 16, 2021
Low immune response rate of HIV-infected patients to a single injection of hepatitis A vaccine.
Journal: Infectious diseases now
Published: March 29, 2020
Persistent low-level viraemia in antiretroviral treatment-experienced patients is not linked to viral resistance or inadequate drug concentrations.
Journal: The Journal of antimicrobial chemotherapy
Published: January 13, 2020
Drastic decrease of the HIV reservoir in a patient treated with nivolumab for lung cancer.
Journal: Annals of oncology : official journal of the European Society for Medical Oncology
Published: December 06, 2017
Darunavir/ritonavir monotherapy at a low dose (600/100 mg/day) in HIV-1-infected individuals with suppressed HIV viraemia.
Journal: The Journal of antimicrobial chemotherapy
Published: July 20, 2017
Anaplastic Kaposi's sarcoma: 5 cases of a rare and aggressive type of Kaposi's sarcoma.
Journal: Annales de dermatologie et de venereologie
Published: July 04, 2017
Dolutegravir as monotherapy in HIV-1-infected individuals with suppressed HIV viraemia.
Journal: The Journal of antimicrobial chemotherapy
Published: February 19, 2016
Factors associated with virological response to a switch regimen containing maraviroc for antiretroviral-experienced HIV-1-infected patients.
Journal: The Journal of antimicrobial chemotherapy
Published: January 14, 2016
Usefulness of an HIV DNA resistance genotypic test in patients who are candidates for a switch to the rilpivirine/emtricitabine/tenofovir disoproxil fumarate combination.
Journal: The Journal of antimicrobial chemotherapy
Published: December 27, 2015
Last Updated: 09/26/2026